Children's National Hospital Trial Shows Bionic Pancreas Improves Type 1 Diabetes Management Compared To Standard Insulin Delivery Methods
September 29, 2022
September 29, 2022
WASHINGTON, Sept. 29 (TNSjou) -- Children's National Hospital issued the following news:
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with Type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Children's National Hospital, was primarily funded by . . .
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with Type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Children's National Hospital, was primarily funded by . . .